Cargando…

Prescription Drug Expenditures, Financial Burden, and Health Plan Satisfaction Among Medicare Beneficiaries

Detalles Bibliográficos
Autor principal:	Curtiss, Frederic R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2003
Materias:	Editorial Subjects In This Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437271/ https://www.ncbi.nlm.nih.gov/pubmed/14613446 http://dx.doi.org/10.18553/jmcp.2003.9.5.453

Ejemplares similares

Effects of Physician Report Cards, Knowledge of Drug Prices, and Financial Incentives in Prescription Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Predictability of Prescription Drug Expenditures for Medicare Beneficiaries
por: Wrobel, Marian V., et al.
Publicado: (2003)

Hypertension, Prescription Drug Copayments, and Drug Therapy Adherence
por: Curtiss, Frederic R.
Publicado: (2003)

Prescription-Equivalent Over-the-Counter Drugs for Allergy, Heartburn, and Cholesterol Reduction
por: Curtiss, Frederic R.
Publicado: (2005)

Clinical, Service, and Cost Outcomes of Computerized Prescription Order Entry
por: Curtiss, Frederic R.
Publicado: (2005)

Clinical Pharmacist Intervention in a Primary Care Medical Group Reduces Financial Losses
por: Curtiss, Frederic R.
Publicado: (2004)

COPD - Whose Burden, How Large, and What to Do About It?
por: Curtiss, Frederic R.
Publicado: (2005)

Prescription Drug Coverage and Spending for Medicare Beneficiaries
por: Poisal, John A., et al.
Publicado: (1999)

Burden of Prescription Drug Costs in the United States
por: Curtiss, Frederic R.
Publicado: (2003)

Psychometric Properties of an Instrument to Assess Medicare Beneficiaries' Prescription Drug Plan Experiences
por: Martino, Steven C., et al.
Publicado: (2009)

Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans
por: Newman, Terri Victoria, et al.
Publicado: (2022)

Medicare Part D: Selected Issues for Plan Sponsors, Pharmacists, and Beneficiaries in 2008
por: DePue, Ronnie, et al.
Publicado: (2008)

3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes
por: Curtiss, Frederic R.
Publicado: (2004)

Preventable Drug-related Morbidity (PDRM)
por: Curtiss, Frederic R.
Publicado: (2003)

Does Persistence With Drugs for Alzheimer's Disease Matter?
por: Curtiss, Frederic R.
Publicado: (2005)

Medicare Beneficiary Knowledge of and Experience with Prescription Drug Cards
por: Rudolph, Noemi V., et al.
Publicado: (2007)

MCBS Highlights: Prescription Drug Coverage Among Medicare Beneficiaries
por: Regan, Joseph F., et al.
Publicado: (2007)

Unraveling the Effects of Tier-Copayment Drug Benefit Designs
por: Curtiss, Frederic R.
Publicado: (2003)

TMAC Savings of 90% for Heartburn Drugs in the United States
por: Curtiss, Frederic R.
Publicado: (2006)

Methods to Attain Optimal Outcomes With Lipid-Lowering Drug Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

Contractual Arrangements Between HMOs and Medical Groups to Manage Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003)

The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
por: Curtiss, Frederic R.
Publicado: (2003)

Clinical, Service, and Cost Outcomes of Drug Coverage Edits and Quanitity Limits
por: Curtiss, Frederic R.
Publicado: (2003)

Drug Formulary Decisions - Evaluating the Risks and Benefits of Hormone Replacement Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

Evidence-Based Medicine: Which Drugs Are Truly Contraindicated for Use in Older Adults?
por: Curtiss, Frederic R.
Publicado: (2005)

Pharmacoeconomic Modeling of Drug Therapies for Multiple Sclerosis - Are We Building Houses on Sand?
por: Curtiss, Frederic R.
Publicado: (2007)

Pressure on Pharmacy Benefit Managers for Disclosure and Demonstration of Value - Rebates and Drug Benegit Cost Savings
por: Curtiss, Frederic R.
Publicado: (2003)

Step-Therapy Edits for PPIs and COX-2 Drugs - What We Do and Do Not Know
por: Curtiss, Frederic R.
Publicado: (2004)

What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?
por: Hung, Anna, et al.
Publicado: (2016)

Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement
por: Yala, Stella M, et al.
Publicado: (2014)

MCBS Highlights: Health Expenditures for Medicare Beneficiaries
por: Murray, Lauren A., et al.
Publicado: (1999)

Prescription Drug Use and Expenditures Among Dually Eligible Beneficiaries
por: Bagchi, Ann D., et al.
Publicado: (2007)

Financial Burdens of Out-of-Pocket Prescription Drug Expenditures under High-Deductible Health Plans
por: Abdus, Salam
Publicado: (2020)

Variation in Estimated Medicare Prescription Drug Plan Costs and Affordability for Beneficiaries Living in Different States
por: Davis, Matthew M., et al.
Publicado: (2007)

Characteristics of Older Adults Who Meet the Annual Prescription Drug Expenditure Threshold for Medicare Medication Therapy Management Programs
por: Daniel, Gregory W., et al.
Publicado: (2007)

Do Medicare Beneficiaries Living With HIV/AIDS Choose Prescription Drug Plans That Minimize Their Total Spending?
por: Desmond, Katherine A., et al.
Publicado: (2017)

Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes
por: He, Qing, et al.
Publicado: (2021)

Medical Cost Offsets from Prescription Drug Utilization Among Medicare Beneficiaries
por: Roebuck, M. Christopher
Publicado: (2014)

Does Closing the Donut Hole Reduce Financial Burdens Among Medicare Part D Beneficiaries?
por: Zhang, Yalu, et al.
Publicado: (2021)

Estimates of Insulin Out-of-Pocket Cap–Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries
por: Li, Minghui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kqc5d8q3qc5nj4fauok11shnuq